Davidson Zhao

Targeting an MDM2/MYC Axis to Overcome Drug Resistance in Multiple Myeloma

Omar Faruq, Davidson Zhao, Mariusz Shrestha et al. · Cancers · 2022 · 29 citations · Full text

Medicine, Cancer Biology, Oncology +14

TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation

Davidson Zhao, Mojgan Zarif, Qianghua Zhou et al. · Cancers · 2023 · 28 citations · Full text

Medicine, Hematology, Oncology +14

NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1

Davidson Zhao, Mojgan Zarif, Entsar Eladl et al. · Leukemia Research · 2022 · 17 citations

Medicine, Genetics, Oncology +10

Molecular characterization of <scp>AML‐MRC</scp> reveals <scp><i>TP53</i></scp> mutation as an adverse prognostic factor irrespective of <scp>MRC</scp>‐defining criteria, <scp><i>TP53</i></scp> allelic state, or <scp><i>TP53</i></scp> variant allele frequency

Davidson Zhao, Entsar Eladl, Mojgan Zarif et al. · Cancer Medicine · 2022 · 17 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia

Qianghua Zhou, Davidson Zhao, Entsar Eladl et al. · Leukemia Research · 2022 · 17 citations

Life Sciences, Genetics, Molecular Genetics +14